PBF-677 ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	2

97. 潰瘍性大腸炎

---

臨床試験数 : 2,527 /  薬物数 : 1,465 - (DrugBank : 259) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03773952 (ClinicalTrials.gov)	July 1, 2018	30/11/2018	Safety and Efficacy of PBF-677 in Ulcerative Colitis Patients	A Phase IIa (Proof of Concept), Randomized, Double Blind, Placebo Controlled, Multicenter Clinical Trial to Evaluate the Safety and Efficacy of Oral Treatment With PBF-677 in Patients With Mild to Moderate Ulcerative Colitis	Ulcerative Colitis	Drug: PBF-677;Drug: Placebo oral capsule	Palobiofarma SL	Qualitecfarma	Completed	18 Years	75 Years	All	34	Phase 2	Spain
2	EUCTR2017-003228-54-ES (EUCTR)	28/05/2018	09/04/2018	A clinical trial to evaluate the safety and efficacy of oral treatment with PBF-677 in patients with mild to moderate ulcerative colitis.	A Phase IIa (proof of concept), randomized, double blind, placebo controlled, multicenter clinical trial to evaluate the safety and efficacy of oral treatment with PBF-677 in patients with mild to moderate ulcerative colitis.	Inflammatory Bowel disease, mild to moderate Ulcerative Colitis;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]	Product Code: PBF-677 INN or Proposed INN: PBF-677	PaloBiofarma S.L.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	30	Phase 2	Spain